These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18222727)

  • 41. Na+/H+ exchange inhibition delays the onset of hypovolemic circulatory shock in pigs.
    Wu D; Arias J; Bassuk J; Doods H; Seidler R; Adams JA; Abraham WM
    Shock; 2008 Apr; 29(4):519-25. PubMed ID: 17724433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P; Pott C; Eckardt L; Breithardt G
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NHE-1: a molecular target for signalling and cell matrix interactions.
    Koliakos G; Paletas K; Kaloyianni M
    Connect Tissue Res; 2008; 49(3):157-61. PubMed ID: 18661333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon-gamma suppresses Na+ -H+ exchanger in cultured human endolymphatic sac epithelial cells.
    Son EJ; Moon IS; Kim SH; Kim SJ; Choi JY
    J Cell Biochem; 2009 Aug; 107(5):965-72. PubMed ID: 19479940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3-Substituted-(5-arylfuran-2-ylcarbonyl)guanidines as NHE-1 inhibitors.
    Lee S; Kim T; Lee BH; Yoo SE; Lee K; Yi KY
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1291-5. PubMed ID: 17189690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis and biological evaluation of novel substituted benzoylguanidine derivatives as potent Na+/H+ exchanger inhibitors.
    Xu WT; Jin N; Xu J; Xu YG; Wang QJ; You QD
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3283-7. PubMed ID: 19433354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Na
    Yeves AM; Ennis IL
    Hipertens Riesgo Vasc; 2020; 37(1):22-32. PubMed ID: 31601481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives.
    Zhang R; Dong J; Xu YG; Hua WY; Wen N; You QD
    Eur J Med Chem; 2009 Sep; 44(9):3771-6. PubMed ID: 19482383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (2-Aryl-5-methylimidazol-4-ylcarbonyl)guanidines and (2-aryl-5-methyloxazol-4-ylcarbonyl)guanidines as NHE-1 inhibitors.
    Lee S; Yi KY; Youn SJ; Lee BH; Yoo SE
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1329-31. PubMed ID: 19201189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetic analysis of the regulation of the Na+/H+ exchanger NHE-1 by osmotic shocks.
    Lacroix J; Poët M; Huc L; Morello V; Djerbi N; Ragno M; Rissel M; Tekpli X; Gounon P; Lagadic-Gossmann D; Counillon L
    Biochemistry; 2008 Dec; 47(51):13674-85. PubMed ID: 19035652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Design, synthesis and Na+/H+ exchanger isoform-1 inhibitory activity of feruloylagmatine analogues].
    Li JM; He Y; Zhou P; Xu YG; Peng JZ; Sheng RZ
    Yao Xue Xue Bao; 2011 Aug; 46(8):936-41. PubMed ID: 22007518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.
    Phillips K; Luk A; Soor GS; Abraham JR; Leong S; Butany J
    Am J Cardiovasc Drugs; 2009; 9(3):177-96. PubMed ID: 19463023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphodiesterase 5 inhibitors: are they cardioprotective?
    Reffelmann T; Kloner RA
    Cardiovasc Res; 2009 Jul; 83(2):204-12. PubMed ID: 19474180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benzimidazol-2-yl or benzimidazol-2-ylthiomethyl benzoylguanidines as novel Na+/H+ exchanger inhibitors, synthesis and protection against ischemic-reperfusion injury.
    Zhang R; Lei L; Xu YG; Hua WY; Gong GQ
    Bioorg Med Chem Lett; 2007 May; 17(9):2430-3. PubMed ID: 17346962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
    van der Meer P; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Erythropoietin in the treatment of heart failure and ischemia].
    Lewartowski B
    Kardiol Pol; 2007 Feb; 65(2):192-7. PubMed ID: 17366366
    [No Abstract]   [Full Text] [Related]  

  • 58. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection.
    Shimizu M; Tropak M; Diaz RJ; Suto F; Surendra H; Kuzmin E; Li J; Gross G; Wilson GJ; Callahan J; Redington AN
    Clin Sci (Lond); 2009 Aug; 117(5):191-200. PubMed ID: 19175358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of myocardial infarction by postischemic administration of the calpain inhibitor A-705253 in comparison to the Na(+)/H(+) exchange inhibitor Cariporide in isolated perfused rabbit hearts.
    Neuhof C; Fabiunk V; Speth M; Möller A; Fritz F; Tillmanns H; Neuhof H; Erdogan A
    Biol Chem; 2008 Dec; 389(12):1505-12. PubMed ID: 18844452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.